Rodina, Anna http://orcid.org/0000-0002-3894-6438
Xu, Chao
Digwal, Chander S. http://orcid.org/0000-0001-8784-1096
Joshi, Suhasini
Patel, Yogita
Santhaseela, Anand R. http://orcid.org/0000-0003-3513-9224
Bay, Sadik
Merugu, Swathi
Alam, Aftab
Yan, Pengrong
Yang, Chenghua
Roychowdhury, Tanaya
Panchal, Palak
Shrestha, Liza
Kang, Yanlong
Sharma, Sahil http://orcid.org/0000-0001-7281-9224
Almodovar, Justina
Corben, Adriana
Alpaugh, Mary L. http://orcid.org/0000-0002-0008-2718
Modi, Shanu
Guzman, Monica L. http://orcid.org/0000-0002-9262-8246
Fei, Teng http://orcid.org/0000-0001-7888-1715
Taldone, Tony
Ginsberg, Stephen D.
Erdjument-Bromage, Hediye
Neubert, Thomas A.
Manova-Todorova, Katia
Tsou, Meng-Fu Bryan
Young, Jason C. http://orcid.org/0000-0002-9158-3090
Wang, Tai http://orcid.org/0000-0001-9984-9634
Chiosis, Gabriela http://orcid.org/0000-0003-0486-6920
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R56 AG061869)
Article History
Received: 8 August 2022
Accepted: 5 June 2023
First Online: 23 June 2023
Competing interests
: Memorial Sloan Kettering Cancer Center holds the intellectual rights to this portfolio. Samus Therapeutics Inc, of which G.C. has partial ownership, and is a member of its scientific advisory board, has licensed the epichaperome portfolio. G.C., A.R. and T.T. are inventors on the licensed intellectual property. All other authors declare no competing interests.